Vice Provost and Dean of Research


Showing 1,501-1,520 of 2,458 Results

  • Timothy Meyer

    Timothy Meyer

    Stanford University Professor of Nephrology, Emeritus

    Current Research and Scholarly InterestsInadequate removal of uremic solutes contributes to widespread illness in the more than 500,000 Americans maintained on dialysis. But we know remarkably little about these solutes. Dr. Meyer's research efforts are focused on identifying which uremic solutes are toxic, how these solutes are made, and how their production could be decreased or their removal could be increased. We should be able to improve treatment if we knew more about what we are trying to remove.

  • Sara Michie

    Sara Michie

    Professor of Pathology (Research), Emerita

    Current Research and Scholarly InterestsLymphocyte/endothelial cell adhesion mechanisms involved in lymphocyte migration to sites of inflammation; regulation of expression of endothelial cell adhesion molecules.

  • Emmanuel Mignot, MD, PhD

    Emmanuel Mignot, MD, PhD

    Craig Reynolds Professor of Sleep Medicine and Professor, by courtesy, of Genetics and of Neurology and Neurological Sciences

    Current Research and Scholarly InterestsThe research focus of the laboratory is the study of sleep and sleep disorders such as narcolepsy and Kleine Levin syndrome. We also study the neurobiological and genetic basis of the EEG and develop new tools to study sleep using nocturnal polysomnography. Approaches mostly involve human genetic studies (GWAS, sequencing), EEG signal analysis (deep learning), and immunology (narcolepsy is an autoimmune disease of the brain). We also work on autoimmune encephalitis.

  • Paul Milgrom

    Paul Milgrom

    Shirley R. and Leonard W. Ely, Jr. Professor in the School of Humanities and Sciences, Professor of Economics, Senior Fellow at SIEPR and Professor, by courtesy, of Economics at the GSB and of Management Science and Engineering

    BioPaul Milgrom is the Shirley and Leonard Ely professor of Humanities and Sciences in the Department of Economics at Stanford University and professor, by courtesy, in the Stanford Graduate School of Business and in the Department of Management Sciences and Engineering. Born in Detroit, Michigan on April 20, 1948, he is a member of both the National Academy of Sciences and the American Academy of Arts and Sciences and a winner of the 2008 Nemmers Prize in Economics, the 2012 BBVA Frontiers of Knowledge award, the 2017 CME-MSRI prize for Innovative Quantitative Applications, and the 2018 Carty Award for the Advancement of Science.

    Milgrom is known for his work on innovative resource allocation methods, particularly in radio spectrum. He is coinventor of the simultaneous multiple round auction and the combinatorial clock auction. He also led the design team for the FCC's 2017 incentive auction, which reallocated spectrum from television broadcast to mobile broadband.

    According to his BBVA Award citation: “Paul Milgrom has made seminal contributions to an unusually wide range of fields of economics including auctions, market design, contracts and incentives, industrial economics, economics of organizations, finance, and game theory.” As counted by Google Scholar, Milgrom’s books and articles have received more than 80,000 citations.

    Finally, Milgrom has been a successful adviser of graduate students, winning the 2017 H&S Dean's award for Excellence in Graduate Education.

  • Carlos Milla

    Carlos Milla

    Professor of Pediatrics (Pulmonary Medicine) and, by courtesy, of Medicine (Pulmonary, Allergy and Critical Care Medicine)

    Current Research and Scholarly InterestsAt Stanford University I developed and currently direct the CF Translational Research Center. The overarching goal of the center is to provide the groundwork to streamline, accelerate, and promote the translation of basic discoveries into effective therapies and interventions to benefit patients affected by cystic fibrosis. My laboratory group currently has three main lines of investigation: respiratory cell biology in CF; remote biochemical monitoring; and lung physiology in young children.

  • D. Craig Miller, M.D.

    D. Craig Miller, M.D.

    Thelma and Henry Doelger Professor of Cardiovascular Surgery, Emeritus

    Current Research and Scholarly InterestsCardiac and heart valve disease with experimental laboratory large animal projects focused on the investigation of left ventricular and cardiac mechanics, bioenergetics, and LV and mitral valve physiology and pathophysiology. Current thrust is aimed at understanding the mitral valve and subvalvular mitral apparatus and transmural LV wall strains, thickening, and myolaminar fiber-sheet mechanics.

    Clinical research interests include thoracic aortic diseases (aortic dissection, aneurysm) and cardiac valvular disease, including surgical treatment, endovascular thoracic aortic stent-graft repair, mitral valve repair, and valve-sparing aortic root replacement.

  • Arnold Milstein

    Arnold Milstein

    Professor of Medicine (General Medical Discipline)

    Current Research and Scholarly InterestsDesign national demonstration of innovations in care delivery that provide more with less. Informed by research on AI-assisted clinical workflow, positive value outlier analysis and triggers of loss aversion bias among patients and clinicians.

    Research on creation of a national index of health system productivity gain.

  • Paul Salomon Mischel

    Paul Salomon Mischel

    Fortinet Founders Professor and Professor, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsMy research bridges cancer genetics, signal transduction and cellular metabolism as we aim to understand the molecular mechanisms that drive cancer development, progression, and drug resistance. We have made a series of discoveries that have identified a central role for ecDNA (extrachromosomal DNA) in cancer development, progression, accelerated tumor evolution and drug resistance.

  • William Mitch

    William Mitch

    Professor of Civil and Environmental Engineering

    BioBill Mitch received a B.A. in Anthropology (Archaeology) from Harvard University in 1993. During his studies, he excavated at Mayan sites in Belize and surveyed sites dating from 2,000 B.C. in Louisiana. He switched fields by receiving a M.S. degree in Civil and Environmental Engineering at UC Berkeley. He worked for 3 years in environmental consulting, receiving his P.E. license in Civil Engineering in California. Returning to UC Berkeley in 2000, he received his PhD in Civil and Environmental Engineering in 2003. He moved to Yale as an assistant professor after graduation. His dissertation received the AEESP Outstanding Doctoral Dissertation Award in 2004. At Yale, he serves as the faculty advisor for the Yale Student Chapter of Engineers without Borders. In 2007, he won a NSF CAREER Award. He moved to Stanford University as an associate professor in 2013.

    Employing a fundamental understanding of organic chemical reaction pathways, his research explores links between public health, engineering and sustainability. Topics of current interest include:

    Public Health and Emerging Carcinogens: Recent changes to the disinfection processes fundamental to drinking and recreational water safety are creating a host of highly toxic byproducts linked to bladder cancer. We seek to understand how these compounds form so we can adjust the disinfection process to prevent their formation.

    Global Warming and Oceanography: Oceanic dissolved organic matter is an important global carbon component, and has important impacts on the net flux of CO2 between the ocean and atmosphere. We seek to understand some of the important abiotic chemical reaction pathways responsible for carbon turnover.

    Sustainability and Persistent Organic Pollutants (POPs): While PCBs have been banned in the US, we continue to produce a host of structurally similar chemicals. We seem to understand important chemical pathways responsible for POP destruction in the environment, so we can design less persistent and problematic chemicals in the future.

    Engineering for Sustainable Wastewater Recycling: The shortage of clean water represents a critical challenge for the next century, and has necessitated the recycling of wastewater. We seek to understand ways of engineer this process in ways to minimize harmful byproduct formation.

    Carbon Sequestration: We are evaluating the formation of nitrosamine and nitraminecarcinogens from amine-based carbon capture, as well as techniques to destroy any of these byproducts that form.

  • John Mitchell

    John Mitchell

    Mary and Gordon Crary Family Professor in the School of Engineering, and Professor, by courtesy, of Electrical Engineering and of Education

    Current Research and Scholarly InterestsProgramming languages, computer security and privacy, blockchain, machine learning, and technology for education

  • Anish Mitra

    Anish Mitra

    Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)

    BioAnish Mitra is a neuroscientist and psychiatrist interested in understanding how neural activity in large-scale networks causes mental illness.

  • Subhasish Mitra

    Subhasish Mitra

    William E. Ayer Professor of Electrical Engineering and Professor of Computer Science

    BioSubhasish Mitra holds the William E. Ayer Endowed Chair Professorship in the Departments of Electrical Engineering and Computer Science at Stanford University. He directs the Stanford Robust Systems Group, serves on the leadership team of the Microelectronics Commons AI Hardware Hub funded by the US CHIPS and Science Act, leads the Computation Focus Area of the Stanford SystemX Alliance, and is the Associate Chair (Faculty Affairs) of Computer Science. His research ranges across Robust Computing, NanoSystems, Electronic Design Automation (EDA), and Neurosciences. Results from his research group have influenced almost every contemporary electronic system and have inspired significant government and research initiatives in multiple countries. He has held several international academic appointments — the Carnot Chair of Excellence in NanoSystems at CEA-LETI in France, Invited Professor at EPFL in Switzerland, and Visiting Professor at the University of Tokyo in Japan. Prof. Mitra also has consulted for major technology companies including AMD (XIlinx), Cisco, Google, Intel, Merck (EMD Electronics), and Samsung.

    In the field of Robust Computing, he has created many key approaches for circuit failure prediction, CASP on-line diagnostics, QED system validation, soft error resilience, and X-Compact test compression. Their adoption by industry is growing rapidly, in markets ranging from cloud computing to automotive systems, under various names (Silicon Lifecycle Management, Predictive Health Monitoring, In-System Test Architecture, In-field Scan, In-fleet Scan). His X-Compact approach has proven essential to cost-effective manufacturing and high-quality testing of almost all 21st century systems. X-Compact and its derivatives enabled billions of dollars of cost savings across the industry.

    In the field of NanoSystems, with his students and collaborators, he demonstrated several firsts: the first NanoSystems hardware among all beyond-silicon nanotechnologies for energy-efficient computing (the carbon nanotube computer), the first 3D NanoSystem with computation immersed in data storage, the first published end-to-end computing systems using resistive memories (Resistive RAM-based non-volatile computing systems delivering 10-fold energy efficiency versus embedded flash), and the first monolithic 3D integration combining heterogeneous logic and memory technologies in silicon foundry. These received wide recognition: cover of NATURE, several Highlights to the US Congress, and highlight as "important scientific breakthrough" by news organizations worldwide.

    Prof. Mitra's honors include the Harry H. Goode Memorial Award (by IEEE Computer Society for outstanding contributions in the information processing field), Newton Technical Impact Award in EDA (test-of-time honor by ACM SIGDA and IEEE CEDA), the University Researcher Award (by Semiconductor Industry Association and Semiconductor Research Corporation to recognize lifetime research contributions), the EDAA Achievement Award (by European Design and Automation Association, for outstanding lifetime contributions to electronic design, automation and testing), the Intel Achievement Award (Intel’s highest honor), and the Distinguished Alumnus Award from the Indian Institute of Technology, Kharagpur. He and his students have published over 15 award-winning papers across 5 topic areas (technology, circuits, EDA, test, verification) at major venues including the Design Automation Conference, International Electron Devices Meeting, International Solid-State Circuits Conference, International Test Conference, Symposia on VLSI Technology/VLSI Circuits, and Formal Methods in Computer-Aided Design. Stanford undergraduates have honored him several times "for being important to them." He is a Fellow of the Association for Computing Machinery (ACM) and the Institute of Electrical and Electronics Engineers (IEEE), and a Foreign Member of Academia Europaea.

  • Daria Mochly-Rosen

    Daria Mochly-Rosen

    George D. Smith Professor of Translational Medicine

    Current Research and Scholarly InterestsTwo areas: 1. Using rationally-designed peptide inhibitors to study protein-protein interactions in cell signaling. Focus: protein kinase C in heart and large GTPases regulating mitochondrial dynamics in neurodegdenration. 2. Using small molecules (identified in a high throughput screens and synthetic chemistry) as activators and inhibitors of aldehyde dehydrogenases, a family of detoxifying enzymes, and glucose-6-phoshate dehydrogenase, in normal cells and in models of human diseases.

  • Everett J. Moding, MD, PhD

    Everett J. Moding, MD, PhD

    Assistant Professor of Radiation Oncology (Radiation Therapy)

    Current Research and Scholarly InterestsMy laboratory performs translational research using analysis of human samples to identify critical mediators of treatment resistance that can be validated in preclinical models and targeted to enhance the efficacy of cancer therapy.